NasdaqGS:UTHRBiotechs
United Therapeutics (UTHR) Net Margin Strength Reinforces Bullish Earnings Narrative
United Therapeutics (UTHR) FY 2025 Earnings Snapshot
United Therapeutics (UTHR) closed FY 2025 with fourth quarter revenue of US$790.2 million and basic EPS of US$8.41, capping a twelve month run where trailing revenue reached US$3.2 billion and EPS came in at US$30.13. Over that period, revenue has moved from US$2.9 billion to US$3.2 billion and EPS has shifted from US$26.44 to US$30.13, giving investors a clear view of how the top line and EPS have tracked together. With a net income of...